Calithera Biosciences (NASDAQ:CALA) Now Covered by StockNews.com

StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research note published on Sunday. The firm issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Stock Performance

Shares of CALA stock opened at $0.00 on Friday. Calithera Biosciences has a one year low of $0.00 and a one year high of $0.12.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.